{"identifier":"nobleid:/w1/20260524/73399940","arkIdentifier":"ark:/48914/w1/20260524/73399940","version":1,"workTitle":"ARCHER: Dacomitinib (D; PF-00299804) versus erlotinib (E) for advanced (adv) non-small cell lung cancer (NSCLC)—A randomized double-blind phase III study.","workType":"Journal Article","authors":"Michael Boyer, Pasi A. Jänne, Tony Mok, Kenneth J. O’Byrne, Luis Paz‐Ares, Suresh S. Ramalingam, Jane Liang, Ian W. Taylor, Alicyn Campbell, Joseph O’Connell","description":null,"workUrl":null,"createdAt":"2026-05-24T21:20:03.378382Z","canonicalUrl":"https://nobleid.org/ark:/48914/w1/20260524/73399940.v1"}